九州通(600998.SH):今年的“雙11”活動中,公司B2C電商總代總銷業務銷售額突破2.16億元
格隆匯11月21日丨九州通(600998.SH)在互動平台表示,公司B2C電商總代總銷業務主要為醫藥生產企業、電商平台提供電商運營、渠道拓展、供應鏈管理等全場景服務,通過“供應鏈+運營+數字化+醫療服務”四位一體模式助力藥械企業實現全網渠道業務的增長。截至2024年三季度末,公司經銷並運營了40餘個知名醫藥健康品牌的線上官方旗艦店,其中上億級運營項目5個,千萬級項目20餘個。2024年前三季度,公司為藥械企業提供“一站式”全網化B2C電商總代總銷服務,實現銷售收入7.23億元,同比增長16.43%。今年的“雙11”活動中,公司B2C電商總代總銷業務銷售額突破2.16億元,訂單量同比增長49%,取得良好成績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.